pComb3XSS Citations (17)
Originally described in: Methods for the generation of chicken monoclonal antibody fragments by phage display.Andris-Widhopf J, Rader C, Steinberger P, Fuller R, Barbas CF 3rd J Immunol Methods. 2000 Aug 28;242(1-2):159-81. PubMed Journal
Articles Citing pComb3XSS
| Articles |
|---|
| Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety. Tang F, LeBlanc ME, Wang W, Liang D, Chen P, Chou TH, Tian H, Li W. Angiogenesis. 2019 Aug;22(3):369-382. doi: 10.1007/s10456-019-09662-4. Epub 2019 Jan 14. PubMed |
| A potent voltage-gated calcium channel inhibitor engineered from a nanobody targeted to auxiliary CaVbeta subunits. Morgenstern TJ, Park J, Fan QR, Colecraft HM. Elife. 2019 Aug 12;8. pii: 49253. doi: 10.7554/eLife.49253. PubMed |
A toolbox of nanobodies developed and validated for use as intrabodies and nanoscale immunolabels in brain neurons.
Dong JX, Lee Y, Kirmiz M, Palacio S, Dumitras C, Moreno CM, Sando R, Santana LF, Sudhof TC, Gong B, Murray KD, Trimmer JS.
Elife. 2019 Sep 30;8. pii: 48750. doi: 10.7554/eLife.48750.
PubMed
Associated Plasmids |
| Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Feng Z, He X, Zhang X, Wu Y, Xing B, Knowles A, Shan Q, Miller S, Hojnacki T, Ma J, Katona BW, Gade TPF, Schrader J, Metz DC, June CH, Hua X. Nat Cancer. 2022 May;3(5):581-594. doi: 10.1038/s43018-022-00344-7. Epub 2022 Mar 21. PubMed |
| Naturally Occurring Anti-Idiotypic Antibodies Portray a Largely Private Repertoire in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Heeb SR, Schaller M, Kremer Hovinga JA. J Immunol. 2022 Jun 1;208(11):2497-2507. doi: 10.4049/jimmunol.2100868. Epub 2022 May 18. PubMed |
| Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins. Yu C, Ding W, Zhu L, Zhou Y, Dong Y, Li L, Liu J, Wang Y, Li Z, Zhu L, Chen F, Ruan M, Qian D, Wang Y, Wu B, Xu H, Li M, Bi Y, Wang H, Wang W, Chao P, Xing L, Shen B, Dai H, Zha L, Zhao H, Wang J. iScience. 2022 Dec 5;26(1):105736. doi: 10.1016/j.isci.2022.105736. eCollection 2023 Jan 20. PubMed |
| Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody-Drug Conjugates. Bordeau BM, Nguyen TD, Polli JR, Chen P, Balthasar JP. Mol Cancer Ther. 2023 Apr 3;22(4):459-470. doi: 10.1158/1535-7163.MCT-22-0440. PubMed |
| A modular phage vector platform for targeted photodynamic therapy of Gram-negative bacterial pathogens. Petrosino A, Saporetti R, Starinieri F, Sarti E, Ulfo L, Boselli L, Cantelli A, Morini A, Zadran SK, Zuccheri G, Pasquini Z, Di Giosia M, Prodi L, Pompa PP, Costantini PE, Calvaresi M, Danielli A. iScience. 2023 Sep 27;26(10):108032. doi: 10.1016/j.isci.2023.108032. eCollection 2023 Oct 20. PubMed |
| A Detailed Protocol for Constructing a Human Single-Chain Variable Fragment (scFv) Library and Downstream Screening via Phage Display. Liu Z, Kim D, Kang S, Jung JU. Methods Protoc. 2024 Feb 1;7(1):13. doi: 10.3390/mps7010013. PubMed |
| An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy. Brisar N, Suster K, Brezar SK, Vidmar R, Fonovic M, Cor A. Viruses. 2024 Feb 1;16(2):232. doi: 10.3390/v16020232. PubMed |
| Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection. Zhao GX, Fang XY, Bu GL, Chen SJ, Sun C, Li T, Xie C, Wang Y, Li SX, Meng N, Feng GK, Zhong Q, Kong XW, Liu Z, Zeng MS. Cell Rep Med. 2024 May 21;5(5):101573. doi: 10.1016/j.xcrm.2024.101573. PubMed |
| Early rhombic lip Protogenin(+ve) stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma. Visvanathan A, Saulnier O, Chen C, Haldipur P, Orisme W, Delaidelli A, Shin S, Millman J, Bryant A, Abeysundara N, Wu X, Hendrikse LD, Patil V, Bashardanesh Z, Golser J, Livingston BG, Nakashima T, Funakoshi Y, Ong W, Rasnitsyn A, Aldinger KA, Richman CM, Van Ommeren R, Lee JJY, Ly M, Vladoiu MC, Kharas K, Balin P, Erickson AW, Fong V, Zhang J, Suarez RA, Wang H, Huang N, Pallota JG, Douglas T, Haapasalo J, Razavi F, Silvestri E, Sirbu O, Worme S, Kameda-Smith MM, Wu X, Daniels C, MichaelRaj AK, Bhaduri A, Schramek D, Suzuki H, Garzia L, Ahmed N, Kleinman CL, Stein LD, Dirks P, Dunham C, Jabado N, Rich JN, Li W, Sorensen PH, Wechsler-Reya RJ, Weiss WA, Millen KJ, Ellison DW, Dimitrov DS, Taylor MD. Cell. 2024 Aug 22;187(17):4733-4750.e26. doi: 10.1016/j.cell.2024.06.011. Epub 2024 Jul 5. PubMed |
| AI-based IsAb2.0 for antibody design. Liang T, Sun ZY, Hines MG, Penrose KJ, Hao Y, Chu X, Mellors JW, Dimitrov DS, Xie XQ, Li W, Feng Z. Brief Bioinform. 2024 Jul 25;25(5):bbae445. doi: 10.1093/bib/bbae445. PubMed |
| Functional Divergence in the Affinity and Stability of Non-Canonical Cysteines and Non-Canonical Disulfide Bonds: Insights from a VHH and VNAR Study. Xu M, Zhao Z, Deng P, Sun M, Chiu CKC, Wu Y, Wang H, Bi Y. Int J Mol Sci. 2024 Sep 11;25(18):9801. doi: 10.3390/ijms25189801. PubMed |
| Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML. Bernasconi-Bisio F, Molina E, Ibarra V, Ibanez-Sala I, Rochira F, Jauregui P, Rodriguez-Diaz S, Martinez-Turrillas R, Azagra-Barber I, Gomez-Cebrian N, Lasarte JJ, Puchades-Carrasco L, Vanrell L, Rodriguez-Madoz JR, Prosper F, Pineda-Lucena A. Mol Ther Oncol. 2025 Feb 11;33(1):200949. doi: 10.1016/j.omton.2025.200949. eCollection 2025 Mar 20. PubMed |
| Development of an Anti-Zearalenone Nanobody Phage Display Library and Preparation of Specific Nanobodies. Zeng Y, Hu Y, Chen G, Feng Q, Wang R, Zhang Z, Chen J, Liao J, Lin D, Zhu W. Curr Issues Mol Biol. 2025 Feb 27;47(3):157. doi: 10.3390/cimb47030157. PubMed |
| Neutralization of the Pandemic Influenza A/H1N1 Virus with Lama glama Humanized Nanobodies (VHH). Paez-Hernandez ZY, Stephano-Hornedo JL, Bolanos-Prats JA, Cordova-Guerrero I, Macias-Alonso M, Marrero JG, Capiz AP, Gonzalez VG. Antibodies (Basel). 2025 May 16;14(2):42. doi: 10.3390/antib14020042. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.